Lincare Holdings Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Lincare Holdings

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Joanne McArdra who wrote (26)	6/2/1998 1:18:00 AM
From: SFJayhawk	Read Replies (2) of 33

LNCR is in the driver seat With the recent meltdown of Apria (AHG), the #1 home oxygen provider, LNCR is well positioned to benefit. The company has almost no debt ($15 MM) with a $2.2 Billion market cap. The company is ramping up its acquistion schedule, in response to many Mom and Pop shops hurting from the recent 25% cut in Medicare reimbursements to home oxygen providers. LNCR's revenues are currently growing 2-3x faster than the current industry average of 8-12%. This company has met or exceeded earnings almost every quarter and looks to continue its ways. Today, the stock just split 2 for 1, thus helping provide for some more liquidity into the stock. Also, the short interest in this stock decreased from 3.5 MM shares in April '98 to 1.5 MM in May '98. Alan

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next